| __timestamp | Pfizer Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 8393000000 | 382096000000 |
| Thursday, January 1, 2015 | 7690000000 | 345927000000 |
| Friday, January 1, 2016 | 7872000000 | 312303000000 |
| Sunday, January 1, 2017 | 7657000000 | 325441000000 |
| Monday, January 1, 2018 | 8006000000 | 368298000000 |
| Tuesday, January 1, 2019 | 8650000000 | 492381000000 |
| Wednesday, January 1, 2020 | 9405000000 | 455833000000 |
| Friday, January 1, 2021 | 13829000000 | 526087000000 |
| Saturday, January 1, 2022 | 11428000000 | 633325000000 |
| Sunday, January 1, 2023 | 10679000000 | 729924000000 |
| Monday, January 1, 2024 | 10930000000 | 729924000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) expenses are a testament to a company's commitment to innovation. Over the past decade, Pfizer Inc. and Takeda Pharmaceutical Company Limited have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Pfizer's R&D expenses have shown a steady increase, peaking in 2021 with a 60% rise from 2014. However, Takeda's R&D spending dwarfs Pfizer's, with a staggering 1,800% higher expenditure in 2023 compared to Pfizer's peak year. This significant difference highlights Takeda's aggressive investment in research, possibly reflecting its strategic focus on expanding its global footprint and diversifying its product pipeline. Notably, the data for 2024 is incomplete, indicating a potential shift or continuation in these trends. As these pharmaceutical giants forge ahead, their R&D investments will likely shape the future of healthcare innovation.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Takeda Pharmaceutical Company Limited
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
R&D Insights: How Takeda Pharmaceutical Company Limited and Madrigal Pharmaceuticals, Inc. Allocate Funds
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and ImmunityBio, Inc.